The overexpression of the lymphangiogenic factors VEGFC and VEGFD, activators of VEGFR3, has been associated with lymph node metastasis and poor outcome in BC patients [21,22]. This evidence concerns the gene FLT4 and metastatic malignant neoplasm in the lymph nodes.